These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 37896201)
1. Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy. Fernandez M; Nigro M; Travagli A; Pasquini S; Vincenzi F; Varani K; Borea PA; Merighi S; Gessi S Pharmaceutics; 2023 Oct; 15(10):. PubMed ID: 37896201 [TBL] [Abstract][Full Text] [Related]
2. Adenosine receptor signaling: a key to opening the blood-brain door. Bynoe MS; Viret C; Yan A; Kim DG Fluids Barriers CNS; 2015 Sep; 12():20. PubMed ID: 26330053 [TBL] [Abstract][Full Text] [Related]
3. Purinergic signaling: A gatekeeper of blood-brain barrier permeation. Wang Y; Zhu Y; Wang J; Dong L; Liu S; Li S; Wu Q Front Pharmacol; 2023; 14():1112758. PubMed ID: 36825149 [TBL] [Abstract][Full Text] [Related]
4. Adenosine receptor signaling modulates permeability of the blood-brain barrier. Carman AJ; Mills JH; Krenz A; Kim DG; Bynoe MS J Neurosci; 2011 Sep; 31(37):13272-80. PubMed ID: 21917810 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of the adenosine A3 receptor, not the A1 or A2 receptors, promote neurite outgrowth of retinal ganglion cells. Nakashima KI; Iwao K; Inoue T; Haga A; Tsutsumi T; Mochita MI; Fujimoto T; Tanihara H Exp Eye Res; 2018 May; 170():160-168. PubMed ID: 29486164 [TBL] [Abstract][Full Text] [Related]
6. The Role of Adenosine Receptors in Psychostimulant Addiction. Ballesteros-Yáñez I; Castillo CA; Merighi S; Gessi S Front Pharmacol; 2017; 8():985. PubMed ID: 29375384 [TBL] [Abstract][Full Text] [Related]
7. Adenosine Receptors in Modulation of Central Nervous System Disorders. Choudhury H; Chellappan DK; Sengupta P; Pandey M; Gorain B Curr Pharm Des; 2019; 25(26):2808-2827. PubMed ID: 31309883 [TBL] [Abstract][Full Text] [Related]
11. Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist. Gao X; Qian J; Zheng S; Changyi Y; Zhang J; Ju S; Zhu J; Li C ACS Nano; 2014 Apr; 8(4):3678-89. PubMed ID: 24673594 [TBL] [Abstract][Full Text] [Related]
12. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview. Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329 [TBL] [Abstract][Full Text] [Related]
13. A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Clark AN; Youkey R; Liu X; Jia L; Blatt R; Day YJ; Sullivan GW; Linden J; Tucker AL Circ Res; 2007 Nov; 101(11):1130-8. PubMed ID: 17901362 [TBL] [Abstract][Full Text] [Related]
14. Ginkgo biloba extract improves brain uptake of ginsenosides by increasing blood-brain barrier permeability via activating A1 adenosine receptor signaling pathway. Liang W; Xu W; Zhu J; Zhu Y; Gu Q; Li Y; Guo C; Huang Y; Yu J; Wang W; Hu Y; Zhao Y; Han B; Bei W; Guo J J Ethnopharmacol; 2020 Jan; 246():112243. PubMed ID: 31541722 [TBL] [Abstract][Full Text] [Related]
15. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers. Gorain B; Choudhury H; Yee GS; Bhattamisra SK Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092 [TBL] [Abstract][Full Text] [Related]
16. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway. Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376 [TBL] [Abstract][Full Text] [Related]
17. Blood-Brain Barrier in a Haemophilus influenzae Type a In Vitro Infection: Role of Adenosine Receptors A Caporarello N; Olivieri M; Cristaldi M; Scalia M; Toscano MA; Genovese C; Addamo A; Salmeri M; Lupo G; Anfuso CD Mol Neurobiol; 2018 Jun; 55(6):5321-5336. PubMed ID: 28921456 [TBL] [Abstract][Full Text] [Related]
18. Substituted 4-phenylthiazoles: Development of potent and selective A Abdelrahman A; Yerande SG; Namasivayam V; Klapschinski TA; Alnouri MW; El-Tayeb A; Müller CE Eur J Med Chem; 2020 Jan; 186():111879. PubMed ID: 31780082 [TBL] [Abstract][Full Text] [Related]
19. Canagliflozin protects against hyperglycemia-induced cerebrovascular injury by preventing blood-brain barrier (BBB) disruption via AMPK/Sp1/adenosine A2A receptor. Liu Z; Hua W; Jin S; Wang Y; Pang Y; Wang B; Zhao N; Song Y; Qi J Eur J Pharmacol; 2024 Apr; 968():176381. PubMed ID: 38341077 [TBL] [Abstract][Full Text] [Related]
20. A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts. Zhou X; Teng B; Tilley S; Mustafa SJ Am J Physiol Heart Circ Physiol; 2013 Dec; 305(11):H1668-79. PubMed ID: 24043252 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]